ArticleFrontiers in immunology2022

Sintilimab induced ICIAM in the treatment of advanced HCC: A case report and analysis of research progress.

Hongxiang Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.